Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

Drug delivery via lipoprotein-based carriers: answering the challenges in systemic therapeutics.

Sabnis N, Lacko AG.

Ther Deliv. 2012 May;3(5):599-608. Review. Erratum in: Ther Deliv. 2012 Jun;3(6):800.

PMID:
22834404
2.

Prospects and challenges of the development of lipoprotein-based formulations for anti-cancer drugs.

Lacko AG, Nair M, Prokai L, McConathy WJ.

Expert Opin Drug Deliv. 2007 Nov;4(6):665-75. Review.

PMID:
17970668
3.

Recent developments and patenting of lipoprotein based formulations.

Lackó AG, Stewart DR, McClain R, Prókai L, McConathy WJ.

Recent Pat Drug Deliv Formul. 2007;1(2):143-5. Review.

PMID:
19075881
4.

Drug delivery systems using polymer nanoassemblies for cancer treatment.

Bae Y.

Ther Deliv. 2010 Sep;1(3):361-3. No abstract available.

PMID:
22816139
5.
6.

Liposomes and inorganic nanoparticles for drug delivery and cancer imaging.

Heneweer C, Gendy SE, Peñate-Medina O.

Ther Deliv. 2012 May;3(5):645-56. Review.

PMID:
22834408
7.

Antibiological barrier nanovector technology for cancer applications.

Sakamoto J, Annapragada A, Decuzzi P, Ferrari M.

Expert Opin Drug Deliv. 2007 Jul;4(4):359-69. Review.

PMID:
17683250
8.

Steroid-coupled liposomes for targeted delivery to tumor.

Jain SK, Jain A, Gulbake A, Shilpi S, Khare P.

Ther Deliv. 2010 Aug;1(2):345-57. Review.

PMID:
22816137
9.

Nanoparticle-assisted combination therapies for effective cancer treatment.

Hu CM, Aryal S, Zhang L.

Ther Deliv. 2010 Aug;1(2):323-34. Review.

PMID:
22816135
10.
11.

[Recent development of natural and reconstituted lipoprotein based nano drug delivery vehicles].

Xu Y, Jin XF, Ping QN, Liu HF, Chen M, Xu XM.

Yao Xue Xue Bao. 2014 Jan;49(1):23-9. Review. Chinese.

PMID:
24783501
12.

Targeting liposomes toward novel pediatric anticancer therapeutics.

Federman N, Denny CT.

Pediatr Res. 2010 May;67(5):514-9. doi: 10.1203/PDR.0b013e3181d601c5. Review.

PMID:
20118828
13.

Surfactant-polymer nanoparticles: a novel platform for sustained and enhanced cellular delivery of water-soluble molecules.

Chavanpatil MD, Khdair A, Panyam J.

Pharm Res. 2007 Apr;24(4):803-10. Epub 2007 Feb 21.

PMID:
17318416
14.

Lipoproteins: from physiological roles to drug delivery potentials.

Hamidi M, Foroozesh M, Zarrin A.

Crit Rev Ther Drug Carrier Syst. 2006;23(6):497-523. Review.

PMID:
17425501
15.

Nanoscale drug delivery for targeted chemotherapy.

Xin Y, Huang Q, Tang JQ, Hou XY, Zhang P, Zhang LZ, Jiang G.

Cancer Lett. 2016 Aug 28;379(1):24-31. doi: 10.1016/j.canlet.2016.05.023. Epub 2016 May 25. Review.

PMID:
27235607
16.

Polymeric nanohybrids and functionalized carbon nanotubes as drug delivery carriers for cancer therapy.

Prakash S, Malhotra M, Shao W, Tomaro-Duchesneau C, Abbasi S.

Adv Drug Deliv Rev. 2011 Nov;63(14-15):1340-51. doi: 10.1016/j.addr.2011.06.013. Epub 2011 Jul 3. Review.

PMID:
21756952
17.

Nanoparticle delivery strategies to target doxorubicin to tumor cells and reduce side effects.

Wang Y, Wei X, Zhang C, Zhang F, Liang W.

Ther Deliv. 2010 Aug;1(2):273-87. Review.

PMID:
22816133
18.

Biophotonic techniques for manipulation and characterization of drug delivery nanosystems in cancer therapy.

Spyratou E, Makropoulou M, Mourelatou EA, Demetzos C.

Cancer Lett. 2012 Dec 31;327(1-2):111-22. doi: 10.1016/j.canlet.2011.12.039. Epub 2012 Jan 17. Review.

PMID:
22265863
19.

Magnetic therapeutic delivery using navigable agents.

Martel S.

Ther Deliv. 2014 Feb;5(2):189-204. doi: 10.4155/tde.13.147. Review.

PMID:
24483196
20.

[Development of antituberculous drugs: current status and future prospects].

Tomioka H, Namba K.

Kekkaku. 2006 Dec;81(12):753-74. Review. Japanese.

PMID:
17240921

Supplemental Content

Support Center